Why Stomach Acid Challenges Probiotic Drinks, and What Microencapsulation Can Do
Share
In this article
- The journey from can to intestine is not automatic
- What stomach acid does, and what it does not tell us
- Why drinks create a special formulation challenge
- Microencapsulation, explained simply
- What does the research say about SCO2 coatings?
- Probiotics plus prebiotic fibre: what “synbiotic” means
- How to read a probiotic drink label
- A practical way to assess product claims
- Making room for a more thoughtful kind of soda
- When to speak with a healthcare professional
- People also ask
- People also ask
Key takeaways
- A probiotic label needs context: strain identity, viable count, storage directions and the point in shelf life when a count is measured all matter.
- Stomach acidity is one of several stresses live cultures may face. Survival varies by organism, product matrix and process, so avoid sweeping claims about every drink.
- Microencapsulation surrounds cells with a protective material. Research on SCO2-formed polymer coatings has examined survival and release in simulated digestive conditions.
- A synbiotic combines live microorganisms and selectively used substrates. The word does not, on its own, promise a particular effect.
- Choose a drink for a flavour and routine you enjoy, read the evidence carefully, and seek medical advice for persistent or worrying symptoms.
The journey from can to intestine is not automatic
People often ask me a simple question: if I drink something labelled with live probiotics, do those organisms reach my intestine alive? The honest answer is that it depends. A microorganism's journey is shaped by its strain, the drink around it, how it was manufactured and stored, and the conditions it encounters after swallowing.
That nuance matters because a count printed on a label can sound definitive. Colony-forming units, or CFU, estimate the viable organisms in a sample under specified laboratory conditions. But a number at the moment of manufacture does not necessarily tell you how many remain by the final day of the product's shelf life. Nor does a high count alone establish that a particular product will produce a particular health outcome.
The digestive tract presents changing environments. Acidity in the stomach is part of normal digestion, but it can be challenging for some microorganisms. Bile and digestive enzymes add further stresses as contents move onward. A beverage has its own conditions too: water activity, acidity, oxygen exposure, sweeteners, flavour ingredients, processing and storage can all affect microbial viability.
This is not a reason to dismiss probiotic foods or drinks. It is a reason to ask better questions. Which strains are present? What evidence supports their use? How is viability measured? Is the count specified through shelf life? What conditions should the product be kept in? Clear answers are more useful than a dramatic number without context.
For a plain-language overview of the technology behind protected cultures, see the science explainer. The founding story explains how the question first took shape.
What stomach acid does, and what it does not tell us
The stomach's acidic environment is part of normal digestion. Its pH varies over time and with meals, medicines and individual physiology. Laboratory studies use simulated gastric fluid to compare formulations under controlled conditions, but that is not the same as a clinical trial in people.
When unprotected cells are exposed to acid, some strains may lose viability more quickly than others. Other strains naturally tolerate acid better. The surrounding food matrix can also make a difference; a culture consumed with food may encounter different conditions than one taken alone. It is therefore inaccurate to say that stomach acid destroys every probiotic, or that every product without a coating is ineffective.
The responsible question is narrower: has this strain, in this formulation, been studied under relevant conditions, and what do the results actually show? Simulated-digestion work can measure survival or release. Human studies can evaluate outcomes in people. One kind of evidence should not be presented as if it were the other.
The National Center for Complementary and Integrative Health notes that probiotic effects can be specific to the organism and health condition, and that much remains to be learned. The National Institutes of Health Office of Dietary Supplements likewise discusses how strain, dose and evidence affect interpretation. A careful label or conversation should preserve those distinctions.
Why drinks create a special formulation challenge
Dry capsules and powders can be formulated with moisture protection. A ready-to-drink beverage is a different engineering problem: cells sit in contact with liquid for weeks or months. Carbonation, an acidic flavour base, oxygen in the headspace, heat during distribution and time on the shelf all need consideration. Each flavour can behave differently, so a stable formulation in one recipe does not automatically prove stability in every recipe.
This is why a useful development programme combines microbiology with beverage craft. A team may assess the ingredients and process, then measure viable counts at more than one time point under defined storage conditions. It should also study taste, appearance and texture, because a product that is technically interesting but unpleasant to drink will not become part of anyone's routine.
The testing plan should match the intended package and market, including filling, transport, storage and refrigeration needs. A count claimed through shelf life needs data for the commercial formulation, not merely a related powder or laboratory sample.
For product teams, stability is an attribute to measure rather than assume from an ingredient's reputation. Details such as the batch, sampling method, enumeration method, temperature and time points make results interpretable. Qualified laboratories can help teams build confidence in the methods.
Microencapsulation, explained simply
Microencapsulation is a family of approaches that place a small active ingredient inside or alongside a protective coating. In probiotic applications, the active ingredient is a living cell. The coating is intended to help it withstand one or more stresses, such as moisture, acid or processing. Materials and techniques differ widely; the word “microencapsulation” does not mean every product behaves the same way.
One approach explored by South African researchers uses supercritical carbon dioxide, often shortened to SCO2, to form polymer coatings around probiotic cells. Carbon dioxide above its critical temperature and pressure has properties that can be useful in processing. In this work, researchers investigated interpolymer complexes and how they influenced bacterial survival under defined laboratory conditions.
A useful mental picture is a raincoat, not a force field. Its performance depends on material, manufacturing conditions and challenge. In food, the coating also needs to behave appropriately later in digestion. Research may examine whether it remains intact in simulated gastric fluid and releases under simulated intestinal conditions.
The peer-reviewed literature includes a 2006 paper on encapsulating probiotics with an interpolymer complex in supercritical carbon dioxide, a 2009 study of survival in simulated gastrointestinal fluids, and a 2014 paper on heat stability. Each study has a particular organism, method and test environment; results do not automatically apply to every coated cell, finished beverage or person.
Read the research summaries on gastric-acid tolerance, heat stability and the broader microencapsulation research page. The summaries link to the source papers and explain the limits of interpreting laboratory findings.

What does the research say about SCO2 coatings?
The 2009 paper by Thantsha and colleagues in the International Journal of Food Microbiology evaluated SCO2-formed interpolymer complexes with Bifidobacterium longum Bb-46 using simulated gastrointestinal fluids. The 2014 study by Thantsha, Labuschagne and Mamvura in the World Journal of Microbiology and Biotechnology investigated heat stability of probiotic bifidobacteria. Earlier work by Moolman and colleagues in the South African Journal of Science examined probiotic encapsulation using an interpolymer complex in supercritical carbon dioxide.
These publications offer a scientific basis for asking whether an individual-cell coating can help protect cultures. They report controlled experiments, but in vitro survival is not proof of a digestive-health benefit in people. A heat-stability test on a defined sample cannot substitute for shelf-life testing of a finished drink in its final can.
Researchers continue to compare encapsulation materials and methods. They also use varied protocols for simulated digestion, so comparing results across papers requires care.
That distinction matters in marketing. A scientifically grounded statement describes the process and the evidence: a coating is designed to protect cells, and studies have assessed survival under specified conditions. A statement that promises a consumer outcome, or claims every organism arrives at a specific destination alive, requires evidence of a different kind. At the moment, we should be precise about what the laboratory has shown and transparent about what still needs validation in the commercial drink.
Probiotics plus prebiotic fibre: what “synbiotic” means
A probiotic is a live microorganism that, when administered in adequate amounts, confers a health benefit on the host. A prebiotic is a substrate selectively used by host microorganisms that confers a health benefit. In 2020, an International Scientific Association for Probiotics and Prebiotics consensus panel defined a synbiotic as a mixture comprising live microorganisms and substrate or substrates selectively utilised by host microorganisms that confers a health benefit on the host.
In everyday language, a synbiotic brings a live microorganism together with a substrate intended to be used selectively by microbes. It is more specific than simply mixing a probiotic with any fibre. A formulation and its communication should be grounded in the relevant evidence, and the definition itself is not a promise that one product will work the same for every person.
For a beverage, the formulation question is practical as well as scientific. Which live cultures are included? What fibre sources and amounts are used? How do those ingredients affect sweetness, mouthfeel, acidity and tolerance? What happens to the live count during storage? The answers belong in the product-development file and, where appropriate, on a clear label.
The ISAPP consensus statement provides a shared definition. Its authors distinguish complementary synbiotics, where components act independently, from synergistic synbiotics, where the substrate is designed to be selectively used by the co-administered microorganism. The word has scientific meaning; using it responsibly means respecting that meaning.

How to read a probiotic drink label
When you pick up a functional drink, give yourself a minute to look beyond the front panel. Start with the microorganism details: are genera, species and strains identified? The strain designation matters because evidence for one strain cannot automatically be applied to another member of the same species. If a blend is listed, ask whether the individual strains and their proportions are disclosed.
Next, look for the CFU statement and ask when it applies. “At manufacture” and “through the end of shelf life” are different claims. Check storage instructions and the expiry date. If the drink requires refrigeration, that is part of its quality plan, not a flaw. If the claim is an ambient shelf life, the manufacturer should have stability evidence for the actual commercial product.
Then consider the product's stated role. Is it simply a tasty drink with live cultures, or does its label make a health claim? A claim about a specific benefit needs appropriate substantiation and must comply with the rules in the country where it is sold. Requirements depend on intended use, product category and the market where the drink is sold. In South Africa, consumers and developers can consult the Department of Health food control resources.
Finally, ask whether you will enjoy it. Taste, price, availability, dietary needs and a realistic routine all matter. Choose an option you understand, and keep a balanced diet at the centre of your approach.
A practical way to assess product claims
I use a four-question checklist with product teams and curious consumers. First: what exactly is in the product? The answer should include ingredients and, for a probiotic, enough strain and count information to interpret the claim. Second: what evidence supports the claim? Is it a laboratory study, a shelf-life test on the final beverage, or a human study on a specific outcome? Each answers a different question.
Third: does the evidence match the words on the pack? A simulated digestion experiment can support a statement about measured survival under those laboratory conditions. It cannot alone establish relief from bloating or substantiate a disease-related claim. Fourth: what should happen if someone has symptoms? A beverage is not a substitute for an assessment by a clinician, especially where symptoms persist, worsen or include warning signs.
For developers, I add a fifth question: has the final recipe been checked in its final package? Culture survival can be affected by flavour acids, sweeteners, manufacturing steps and storage. If a formula changes, retesting may be needed. Consumer trust is built by publishing the conditions, stating limits and updating claims when better data becomes available.

Making room for a more thoughtful kind of soda
The idea behind this project is to explore whether the familiar pleasure of a sparkling soda can sit alongside live cultures and prebiotic fibre, with microencapsulation as a protection strategy. Learn more about the drink concept and the flavour range. Its pre-launch formulation is designed around 1 billion CFU per 355 ml can, 3 g of prebiotic fibre, under 2 g of sugar and 30 calories. Those are product specifications, not a promise of a health outcome, and they must be confirmed through commercial validation and final labelling.
The phrase “the world's first SCO2 microencapsulated synbiotic soda” describes a specific technology-and-format distinction. It should not be shortened to an unqualified claim that it is the first synbiotic soda: other live-culture and prebiotic sodas already exist. We are interested in the narrower question of how a particular microencapsulation platform can be applied in a carbonated, ambient beverage.
That work calls for careful collaboration between microbiologists, flavour specialists, beverage manufacturers and regulators. A successful drink has to taste excellent, remain stable under its intended conditions and communicate honestly. The most important milestones are not slogans. They are repeatable test methods, acceptable sensory results, appropriate shelf-life data and claims that can be supported in each market.
I am optimistic because beverage innovation is strongest when the science and the pleasure of drinking meet. But optimism is not a substitute for testing. In our development work, we are assessing how protected cultures perform in the finished sparkling liquid, across flavours and storage conditions. That is the next evidence to build, alongside the published research on the encapsulation platform.
When to speak with a healthcare professional
Changes in digestion are common, but persistent or severe symptoms deserve attention. Please seek medical advice for ongoing abdominal pain, unexplained weight loss, blood in stool, recurrent vomiting, difficulty swallowing, fever with gastrointestinal symptoms, or a sudden and lasting change in bowel habits. These signs can have many causes and should not be self-diagnosed with a drink, supplement or social-media checklist.
People who are immunocompromised, critically ill, have a central venous catheter, or are managing a serious medical condition should speak with their clinician before using probiotic products. The NCCIH safety overview describes the importance of discussing probiotics with a healthcare provider, particularly for people with underlying health problems. If you take prescribed medicines, ask a pharmacist or doctor about possible considerations rather than changing your care plan yourself.
A probiotic beverage is a food choice, not medical care. If you are simply curious, start with a label you can understand, follow its storage instructions and notice whether you enjoy the flavour. If you are trying to address symptoms, bring your questions to a qualified healthcare professional. That is the most reliable route to advice tailored to you.
People also ask
People also ask
Does stomach acid destroy all probiotics?
No. Survival varies by strain, formulation, food matrix, dose, storage and the conditions used in testing. Some strains tolerate acid better than others, and protective technologies such as microencapsulation are studied to improve survival. A product-specific claim should be supported by appropriate tests rather than generalized to all probiotics.
What does microencapsulation mean in a probiotic drink?
Microencapsulation surrounds a small active ingredient, such as a live microbial cell, with a protective material. Different methods and coating materials behave differently. SCO2 is one process studied for forming polymer coatings, but the finished beverage still needs testing for viability, stability, release and sensory quality.
Is a higher CFU count always better?
Not necessarily. CFU is a count of viable microorganisms, but usefulness depends on the strain, intended use, evidence, dose and how many organisms remain viable through the stated shelf life. A large number at manufacture does not by itself establish a health effect.
What is the difference between a probiotic and a synbiotic?
A probiotic is a live microorganism that, when administered in adequate amounts, confers a health benefit on the host. A synbiotic combines live microorganisms with substrates selectively used by host microorganisms and conferring a health benefit. The label and evidence should fit the product's formulation and claims.
Can a probiotic soda address digestive symptoms?
A beverage should not be relied on as medical care for symptoms. Evidence and effects vary by strain and condition, and ongoing or severe symptoms deserve medical advice. Choose products for taste and transparent information, and consult a healthcare professional about individual needs.
What does Fizzoy contain?
The current pre-launch formulation is designed around 1 billion CFU of live probiotics per 355 ml can, 3 g of prebiotic fibre, under 2 g of sugar and 30 calories. Final commercial specifications, shelf-life testing and labels must be confirmed before launch. It is described as the world's first SCO2 microencapsulated synbiotic soda, a narrowly defined claim.
If you want a practical next step: this article was written while we build Fizzoy, the world's first SCO2 microencapsulated synbiotic soda (1 billion live probiotics, 3 g prebiotic fibre, under 2 g sugar, 30 calories a can). It is not on sale yet. Join the waitlist to hear when the first cans ship, and speak to your doctor or pharmacist if you have a medical condition.

About the author
Dr. Chomba Chuma, MD · LinkedIn
Medical doctor with more than 25 years across clinical medicine, the pharmaceutical industry and nutritional science, and the founder of Velobiotics, the South African probiotics company behind ten specialist brands sold in South Africa, the United States and East Africa. Dr. Chuma writes to bridge the gap between laboratory research and everyday health decisions. His articles are educational and do not replace individual medical advice.